02620nas a2200253   4500008004100000020002300041024001400064245010200078210006900180260001600249300001200265490000600277520186800283100002002151700001802171700002502189700001702214700002002231700001902251700002002270700001502290700001602305856004502321       2016                        eng d  a0973-68830973-6883  a10157413700aDengue Virus Transmission from Living Donor to Recipient in Liver Transplantation: A Case Report.0 aDengue Virus Transmission from Living Donor to Recipient in Live  aIndiac2016  a59 - 610 v63 aMany infections are transmitted from a donor to a recipient through organ transplantations. The transmission of dengue virus from a donor to a recipient in liver transplantation is a rare entity, and currently, there is no recommendation for screening this virus prior to transplantation. We report a case of transmission of dengue virus from donor to recipient after liver transplantation. The recipient had a history of multiple admissions for hepatic encephalopathy and ascites. He was admitted in the ICU for 15 days for chronic liver disease, ascites, and acute kidney injury before transplantation. The donor was admitted 1 day before transplantation. The donor spiked fever on postoperative day 2 followed by thrombocytopenia and elevated liver enzymes. The donor blood test was positive for dengue NS1 antigen. The recipient also had a similar clinical picture on postoperative day 5 and his blood test was also positive for dengue NS1 antigen. Hence, the diagnosis for posttransplant donor-derived allograft-related transmission of dengue infection was made. Both recipient and donor were treated with supportive measures and discharged after their full recovery on postoperative days 9 and 18, respectively. The effect of immunosuppression on dengue presentation is still unclear and there is lack of literature available. In our case, the recipient developed dengue fever similar to general population without showing any feature of severe graft dysfunction. We have concluded that dengue virus can also be transmitted from donor to recipient, and immunosuppression did not have any adverse effect on the evolution of dengue fever within the recipient. Delhi being a hyperendemic zone, screening for donors (especially in season time) for dengue virus seems to be the best preventive method to control donor-derived transmission of dengue to recipient.1 aGupta, Raman, K1 aGupta, Gaurav1 aChorasiya, Vishal, K1 aBag, Pradyut1 aShandil, Rajeev1 aBhatia, Vikram1 aWadhawan, Manav1 aVij, Vivek1 aKumar, Ajay  uhttps://notifylibrary.org/reference/4588